Connect with us

Health

Coronavirus: AstraZeneca to make 30m vaccine doses — if it works – Yahoo Sports

Published

on


Screen grab taken from video issued by Britain's Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine, untaken by Oxford University in England, Thursday April 23, 2020. Two volunteers have received the first vaccine trial against the COVID-19 Coronavirus on Thursday. (Oxford University Pool via AP)
Screen grab taken from video issued by Britain’s Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine. (Oxford University Pool via AP)
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="FTSE 100 drug giant AstraZeneca (AZN.L) is lined up to make as many as 30 million doses of a potential COVID-19 vaccine if ongoing trials prove the drug to be effective.” data-reactid=”23″>FTSE 100 drug giant AstraZeneca (AZN.L) is lined up to make as many as 30 million doses of a potential COVID-19 vaccine if ongoing trials prove the drug to be effective.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="UK business secretary Alok Sharma said on Sunday that AstraZeneca would make up to 30 million doses of an Oxford University-developed drug by September. The drugs giant has agreed to make 100 million doses in total.” data-reactid=”24″>UK business secretary Alok Sharma said on Sunday that AstraZeneca would make up to 30 million doses of an Oxford University-developed drug by September. The drugs giant has agreed to make 100 million doses in total.

The vaccine, known as ChAdOx1 nCoV-19, is being developed by the Jenner Institute and Oxford Vaccine Group at the University of Oxford. Clinical trials began in April with early results coming as soon as this month.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Details of the production partnership between AstraZeneca and Oxford University had previously been announced but Sunday marked the first time production goals had been shared.” data-reactid=”26″>Details of the production partnership between AstraZeneca and Oxford University had previously been announced but Sunday marked the first time production goals had been shared.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="“Our scientists are at the forefront of vaccine development,” business secretary Sharma said in a statement. “This deal with AstraZeneca means that if the Oxford University vaccine works, people in the UK will get the first access to it, helping to protect thousands of lives.”” data-reactid=”27″>“Our scientists are at the forefront of vaccine development,” business secretary Sharma said in a statement. “This deal with AstraZeneca means that if the Oxford University vaccine works, people in the UK will get the first access to it, helping to protect thousands of lives.”

The business secretary announced £65.5m in new funding for the Oxford trials, alongside £18.5m for researchers at Imperial College London.

AstraZeneca chief executive Pascal Soriot thanked the government for its support in a statement and said he was “proud” to be working with Oxford on vaccine development.

Sir John Bell, Regius Professor of Medicine at Oxford University, said in a statement: “We now have a partner in AstraZeneca who are ideally positioned to help us evaluate the vaccine, manufacture it and distribute it to UK citizens as well as to the rest of the world.

“They share our commitment to true global access to end this pandemic.”

Soriot said: “Our company is working hard to establish parallel supply agreements with other nations and multilateral organisations to ensure fair and equitable access around the world.”

Shares in AstraZeneca rose 1.8% on Monday morning in London.

<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Watch the latest videos from Yahoo UK” data-reactid=”34″>Watch the latest videos from Yahoo UK

Let’s block ads! (Why?)



Source link

Continue Reading

Health

No new cases of COVID-19 in Manitoba on Saturday – News 4

Published

on


Graphic

Let’s block ads! (Why?)



Source link

Continue Reading

Health

No new coronavirus cases in Manitoba on Saturday – MSN Canada

Published

on








© THE CANADIAN PRESS/Paul Chiasson
A nurse prepares a testing swab at a temporary coronavirus test clinic in Montreal, on Friday, May 15, 2020. THE CANADIAN PRESS/Paul Chiasson

Manitoba health officials say there are no new cases of the coronavirus identified as of Saturday morning.

Health officials say the total number of lab-confirmed positive and probable cases in the province remains at 300.

READ MORE: Safety officers heading to Manitoba beaches amid COVID-19, no new cases reported Thursday

There are nine active cases as of Friday and 284 individuals who have recovered from COVID-19.

The number of deaths due to COVID-19 remains at seven.

Video: Coronavirus outbreak: Canada now at 92,748 confirmed COVID-19 cases, 7,414 deaths (Global News)

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Public health working to contain latest COVID-19 outbreaks – StCatharinesStandard.ca

Published

on




Public health working to contain latest COVID-19 outbreaks | StCatharinesStandard.ca


Top Stories

Top Stories


Let’s block ads! (Why?)



Source link

Continue Reading

Trending